Page last updated: 2024-10-31

nafamostat and Reperfusion Injury

nafamostat has been researched along with Reperfusion Injury in 12 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
" This study clarifies the effects of nafamostat mesilate (NM), a strong serine protease inhibitor, and FR167653, a suppressant of both tumor necrosis factor-alpha and interleukin-1beta release, on warm ischemia-reperfusion injury and establishes the procurement of the grafts for a successful liver transplant using uncontrolled NHBDs."3.72Effects of anti-inflammatory cytokine agent (FR167653) and serine protease inhibitor on warm ischemia-reperfusion injury of the liver graft. ( Miyagi, S; Ohkohchi, N; Oikawa, K; Satoh, M; Satomi, S; Tsukamoto, S, 2004)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (50.00)18.2507
2000's4 (33.33)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ryu, HG1
Jung, CW1
Lee, CS1
Lee, J1
Gobbetti, T1
Cenac, N1
Motta, JP1
Rolland, C1
Martin, L1
Andrade-Gordon, P1
Steinhoff, M1
Barocelli, E1
Vergnolle, N1
Miyagi, S1
Ohkohchi, N2
Oikawa, K1
Satoh, M1
Tsukamoto, S2
Satomi, S2
Ishimaru, K1
Mitsuoka, H1
Unno, N1
Inuzuka, K1
Nakamura, S1
Schmid-Schönbein, GW2
Urushihara, T2
Sumimoto, K2
Sumimoto, R2
Ikeda, M2
Fukuda, Y2
Dohi, K2
Shimizu, Y1
Nakai, I1
Morita, S1
Uchiyama, K1
Yoshimura, T1
Itokawa, Y1
Oka, T1
Yamanaka, K1
Okugawa, K1
Sakimoto, H1
Nishihara, M1
Kimura, T1
Andoh, A1
Fujiyama, Y1
Saotome, T1
Bamba, T1
Fukumori, T1
Orii, T1
Asakura, T1
Takayama, J1
Shibuya, H1
Kato, H1
Kistler, EB1
Lefer, AM1
Hugli, TE1
Kirschfink, M1
Kuratani, T1
Matsuda, H1
Sawa, Y1
Kaneko, M1
Nakano, S1
Kawashima, Y1

Reviews

1 review available for nafamostat and Reperfusion Injury

ArticleYear
Targeting complement in therapy.
    Immunological reviews, 2001, Volume: 180

    Topics: Anaphylatoxins; Angioedema; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Antibo

2001

Trials

1 trial available for nafamostat and Reperfusion Injury

ArticleYear
Nafamostat mesilate attenuates Postreperfusion Syndrome during liver transplantation.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2011, Volume: 11, Issue:5

    Topics: Adult; Benzamidines; Double-Blind Method; Female; Guanidines; Humans; Infusions, Intravenous; Kallik

2011

Other Studies

10 other studies available for nafamostat and Reperfusion Injury

ArticleYear
Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.
    The American journal of pathology, 2012, Volume: 180, Issue:1

    Topics: alpha-Macroglobulins; Animals; Benzamidines; Chemokines; Cysteine Proteinase Inhibitors; Granulocyte

2012
Effects of anti-inflammatory cytokine agent (FR167653) and serine protease inhibitor on warm ischemia-reperfusion injury of the liver graft.
    Transplantation, 2004, May-27, Volume: 77, Issue:10

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Benzamidines; Bile; Cyclooxygena

2004
Pancreatic proteases and inflammatory mediators in peritoneal fluid during splanchnic arterial occlusion and reperfusion.
    Shock (Augusta, Ga.), 2004, Volume: 22, Issue:5

    Topics: Animals; Arteries; Benzamidines; Blood Pressure; Cardiovascular System; Endopeptidases; Enzyme Inhib

2004
Nafamostat mesilate rinse solution improves graft survival after rat pancreas and heart preservation.
    Transplantation proceedings, 1995, Volume: 27, Issue:1

    Topics: Adenosine; Allopurinol; Animals; Benzamidines; Glutathione; Graft Survival; Guanidines; Heart; Heart

1995
Nafamostat mesilate prevents warm ischemia-reperfusion injury in canine pancreas autotransplantation.
    Transplantation proceedings, 1995, Volume: 27, Issue:6

    Topics: Animals; Benzamidines; Dogs; Guanidines; Male; Nitrites; Pancreas; Pancreas Transplantation; Proteas

1995
Prevention of reperfusion injury after rat pancreas preservation using rinse solution containing nafamostat mesilate.
    Transplantation proceedings, 1996, Volume: 28, Issue:3

    Topics: Adenosine; Allopurinol; Animals; Benzamidines; Blood Glucose; Glutathione; Graft Survival; Guanidine

1996
A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats.
    Clinical and experimental immunology, 1998, Volume: 111, Issue:3

    Topics: Anaphylatoxins; Animals; Benzamidines; Cell Degranulation; Cell Membrane Permeability; Chelating Age

1998
Elimination of Kupffer cells and nafamostat mesilate rinse prevent reperfusion injury in liver grafts from agonal non-heart-beating donors.
    Transplantation, 1999, Jun-15, Volume: 67, Issue:11

    Topics: Adenosine Triphosphate; Animals; Benzamidines; Bilirubin; Cell Survival; Energy Metabolism; Guanidin

1999
Plasma activation during splanchnic arterial occlusion shock.
    Shock (Augusta, Ga.), 2000, Volume: 14, Issue:1

    Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Benzamidines; Biological Factors; Cats; Celiac

2000
Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass.
    The Journal of thoracic and cardiovascular surgery, 1992, Volume: 103, Issue:3

    Topics: Adenosine Triphosphate; Animals; Benzamidines; Blood; Cardiopulmonary Bypass; Constriction; Guanidin

1992